Work with LifeSpan to design a custom immunohistochemistry to address your specific biological question. Outsource the entire localization process without having to
worry about finding and characterizing target specific antibodies, sourcing and validating difficult-to-find tissues, and having the ability to interpret the resulting
immunostaining in relation to complex human pathologies.
TCR Screening Services
Test your therapeutic antibodies in immunohistochemistry against a broad panel of normal frozen human tissue types in order to determine potential unintended binding.
Our non-GLP TCR services are designed on the FDA recommendation outlined in their "Points to Consider in the Manufacture and Testing of Monoclonal Antibody Products for Human Use".
PLA2G16 Antibody, AdPLA Antibody, Adipose-specific PLA2 Antibody, Group XVI phospholipase A1/A2 Antibody, Group XVI phospholipase A2 Antibody, H-REV107-1 Antibody, HRAS-like suppressor 3 Antibody, HRASLS3 Antibody, HREV107-3 Antibody, HRAS-like suppressor 1 Antibody, HREV107-1 Antibody, H-rev 107 protein homolog Antibody, HREV107 Antibody, HRSL3 Antibody, Phospholipase A2, group XVI Antibody
Exhibits PLA1/2 activity, catalyzing the calcium-independent hydrolysis of acyl groups in various phosphatidylcholines (PC) and phosphatidylethanolamine (PE). For most substrates, PLA1 activity is much higher than PLA2 activity. Specifically catalyzes the release of fatty acids from phospholipids in adipose tissue By similarity. N- and O-acylation activity is hardly detectable. Might decrease protein phosphatase 2A (PP2A) activity.